Do you offer OEM or ODM services?

Yes, we provide both OEM and ODM services for customized veterinary medicine solutions.

What are the payment terms accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

How long is the average lead time?

The average lead time is one month for both peak and off-peak seasons.

Albendazole and Ivermectin Powder

Name: Albendazole and Ivermectin Powder
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1953164612

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$0.99-3.99

1 kg

Sample price:US$1.00/kg.Request sample

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

chemical soluble powder

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Moisture Proof

Veterinary Reg. No.

160227415

Transport Package

25kg

Specification

1kg/bag

Trademark

MOOSUN

Origin

Zhengzhou, Henan Province

HS Code

3004909099

Production Capacity

1500 Tons/Year

Key features

Broad-Spectrum Efficacy: Highly effective against 99% of parasites including nematodes, tapeworms, mites, and ticks.

Dual-Action Formula: Combines Albendazole and Ivermectin for comprehensive deworming and ectoparasite control.

Low Toxicity Profile: Features low toxicity for livestock while maintaining high potency against various parasites.

Long Shelf Life: Ensures product stability and efficacy for up to 2 years when stored properly.

Manufacturer Direct: Direct supply from a manufacturer with 20 R&D engineers and established production facilities.

Customization Support: ODM and OEM services available for tailored veterinary medicine solutions.

Fast Delivery: Consistent one-month lead time available during both peak and off-peak seasons.

Global Market Reach: Exporting to North America, Europe, Southeast Asia, and other major international markets.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.82h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.